Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Early palliative care may boost quality of life in advanced GI cancers

NCT ID NCT02246725

Symptom relief Sponsor: Lund University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at whether early contact with a palliative care unit improves quality of life for people with advanced cancers of the upper gastrointestinal tract or colorectal cancer. 108 participants were randomly assigned to either early palliative care or standard care (contact when needed). The researchers measured quality of life, anxiety, and survival. The goal is to see if starting palliative care earlier makes a meaningful difference for patients and their families.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If it works, this could show that early palliative care improves quality of life and possibly survival for people with advanced gastrointestinal cancers.
What could go wrong
This is a small, completed study with 108 participants. The results may not apply to all cancer types or stages, and the intervention is supportive care, not a treatment for the cancer itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

108 people

The number who actually took part.

Start date

Oct 2014

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with tumor in esophagus, stomach, pancreas liver-biliary passage receiving first line palliative chemotherapy, or patients with colorectal cancer receiving second line palliative chemotherapy.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with tumor in upper gastrointestinal canal, who is going to start treatment with first line palliative chemotherapy * Patients with colorectal cancer, who is going to start treatment with second line palliative chemotherapy * Signed written informed concent Exclusion Criteria: * Patients with neuroendocrine tumor * Patients with already ongoing chemotherapy * Patients with already established contact with palliative care unit

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm Depression digestive system cancer Digestive System Diseases digestive system disorder digestive system neoplasm Digestive System Neoplasms intestinal cancer intestinal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Tumor in upper gastrointestinal canal or patients with colorectal cancer

Contacts and locations

Locations

  • Lund University Hospital

    Lund, 221 85, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.